Kathleen Laporte - 01 Nov 2021 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Kathleen LaPorte
Issuer symbol
ETNB
Transactions as of
01 Nov 2021
Net transactions value
$0
Form type
4
Filing time
03 Nov 2021, 16:36:41 UTC
Previous filing
12 Oct 2021
Next filing
13 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 01 Nov 2021 Common Stock 25,000 $18.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, which will vest in equal installments on November 1, 2022, November 1, 2023 and November 1, 2024, subject to the Reporting Person's continued service to the Issuer through each vesting date.